Risperidone, drug interactions

DeVane, C.L. and NemerolF, C.B. (2001) An evaluation of risperidone drug interactions. Journal of Clinical Psychopharmacology, 21, 408—416. 

Ejsing, T. B., Pedersen, A. D., and Linnet, K. (2005) P-glycoprotein interaction with risperidone and 9-OH-iisperidone studied in vitro, in knock-out mice and in drug-drug interaction experiments. Hum. Psychopharmacol. 20, 493-500. 

Spina E, Avenoso A, Scordo MG, Ancione M, Madia A, Gatti G, Perucca E. Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia a clinically relevant pharmacokinetic drug interaction. J Clin Psychopharmacol 2002 22(4) 419-23. 

Eap CB, Bondolfi G, Zullino D, Bryois C, Fuciec M, Savary L, Jonzier-Perey M, Baumann P. Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test. Ther Drug Monit 2001 23(3) 228-31. 

Spina E, Scordo MG, Avenoso A, Perucca E. Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity. J Clin Psychopharmacol 2001 21(l) 108-9. 

Sanderson DR. Drug interaction between risperidone and phenytoin resulting in extrapyramidal symptoms. J Clin Psychiatry 1996 57(4) 177. 

Nakagami T, Yasui-Furukori N, Saito M, Mihara K, De Vries R, Kondo T, Kaneko S. Thioridazine inhibits risperidone metabolism a clinically relevant drug interaction. J Clin Psychopharmacol 2005 25 89-91. 

Alfaro CL, Nicolson R, Lenane M, Rapoport JL. Carbamazepine and/or fluvoxamine drug interaction with risperidone in a patient on multiple psychotropic medications. Ann Pharmacother 2000 34(l) 122-3. 

---